Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cell cycle specific inhibitors

B K Bhuyan1, V E Groppi

  • 1Upjohn Company, Kalamazoo, MI 49001.

Pharmacology & Therapeutics
|January 1, 1989
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The selective alpha7 nicotinic acetylcholine receptor agonist PNU-282987 [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats.

The Journal of pharmacology and experimental therapeutics·2004
Same author

The DBA/2J strain and prepulse inhibition of startle: a model system to test antipsychotics?

Psychopharmacology·2001
Same author

Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels.

Nature·1997
Same author

Assessment of microtubule stabilizers by semiautomated in vitro microtubule protein polymerization and mitotic block assays.

Cancer chemotherapy and pharmacology·1997
Same author

Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.

Cancer chemotherapy and pharmacology·1995
Same author

V79 Chinese hamster lung cells resistant to the bis-alkylator bizelesin are multidrug-resistant.

Cancer chemotherapy and pharmacology·1994
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
Same journal

A-type potassium channels in pain signaling: Fundamental mechanisms and pathophysiological roles.

Pharmacology & therapeutics·2026
See all related articles